Xiaolin Wang Sc.D
Executive Vice President and Clinical Development Jack Anders
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Revolution Medicines, Inc. (RVMD) | Executive Vice President and Clinical Development | $400,000 | $1,791,780 |
| 2021 | Revolution Medicines, Inc. (RVMD) | Executive Vice President and Clinical Development | $377,833 | $2,167,809 |
Earnings-call appearances
No earnings-call appearances recorded yet.